Note 9 - Earnings Per Share

3 Months Ended

Sep. 30, 2021

Notes to Financial Statements

Earnings Per Share [Text Block]

Note 9. Earnings Per Share:

The following table reflects the calculation of basic and diluted earnings per share (in thousands, except per share amounts):

	Quarter Ended September 30,
	2021			2020
Earnings per share – basic:
Net earnings, including noncontrolling interest	$	68,981		$	33,395
Less net earnings (loss) attributable to noncontrolling interest		(634	)		-
Net earnings attributable to Bio-Techne	$	69,615		$	33,395
Income allocated to participating securities		(36	)		(21)
Income available to common shareholders	$	69,579		$	33,374
Weighted-average shares outstanding - basic		39,094			38,536
Earnings per share - basic	$	1.78		$	0.87
Earnings per share – diluted:
Net earnings, including noncontrolling interest	$	68,981		$	33,395
Less net earnings (loss) attributable to noncontrolling interest		(634	)		-
Net earnings attributable to Bio-Techne	$	69,615		$	33,395
Income allocated to participating securities		(36	)		(21	)
Income available to common shareholders	$	69,579		$	33,374
Weighted average shares outstanding - basic		39,094			38,536
Dilutive effect of stock options and restricted stock units		2,064			1,489
Weighted average common shares outstanding - diluted		41,158			40,025
Earnings per share - diluted	$	1.69		$	0.83

The dilutive effect of stock options and restricted stock units in the above table excludes all options for which the aggregate exercise proceeds exceeded the average market price for the period. The number of potentially dilutive option shares excluded from the calculation was 0.4 million and 1.5 million for the quarter ended September 30, 2021 and 2020, respectively.